- Home
- MARPS vs ONVO Comparison
MARPS vs ONVO Comparison
Compare MARPS & ONVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MARPS
- ONVO
- Stock Information
- Founded
- MARPS 1956
- ONVO 2007
- Country
- MARPS United States
- ONVO United States
- Employees
- MARPS N/A
- ONVO N/A
- Industry
- MARPS Oil & Gas Production
- ONVO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MARPS Energy
- ONVO Health Care
- Exchange
- MARPS Nasdaq
- ONVO Nasdaq
- Market Cap
- MARPS 7.9M
- ONVO 7.2M
- IPO Year
- MARPS N/A
- ONVO N/A
- Fundamental
- Price
- MARPS $3.95
- ONVO $0.32
- Analyst Decision
- MARPS
- ONVO
- Analyst Count
- MARPS 0
- ONVO 0
- Target Price
- MARPS N/A
- ONVO N/A
- AVG Volume (30 Days)
- MARPS 8.4K
- ONVO 89.1K
- Earning Date
- MARPS 01-01-0001
- ONVO 11-26-2024
- Dividend Yield
- MARPS 8.71%
- ONVO N/A
- EPS Growth
- MARPS N/A
- ONVO N/A
- EPS
- MARPS 0.36
- ONVO N/A
- Revenue
- MARPS $1,042,513.00
- ONVO $103,000.00
- Revenue This Year
- MARPS N/A
- ONVO $59.08
- Revenue Next Year
- MARPS N/A
- ONVO $18.24
- P/E Ratio
- MARPS $10.88
- ONVO N/A
- Revenue Growth
- MARPS N/A
- ONVO N/A
- 52 Week Low
- MARPS $3.77
- ONVO $0.35
- 52 Week High
- MARPS $6.50
- ONVO $1.74
- Technical
- Relative Strength Index (RSI)
- MARPS 39.36
- ONVO 31.18
- Support Level
- MARPS $3.92
- ONVO $0.39
- Resistance Level
- MARPS $4.09
- ONVO $0.46
- Average True Range (ATR)
- MARPS 0.11
- ONVO 0.04
- MACD
- MARPS -0.02
- ONVO -0.01
- Stochastic Oscillator
- MARPS 0.00
- ONVO 1.54
About MARPS Marine Petroleum Trust Units of Beneficial Interest
Marine Petroleum Trust is a U.S based royalty trust. It provides administration and liquidation of rights to payments from oil and natural gas leases in the Gulf of Mexico. The Trust's subsidiary holds title to interests in properties which are situated offshore of Louisiana. The revenues of the trust are derived from the oil and natural gas production activities of third parties.
About ONVO Organovo Holdings Inc.
Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.